Israel Englander Takeda Pharmaceutical CO LTD Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Millennium Management LLC holds 250,000 shares of TAK stock, worth $3.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

250,000

Previous 4,346,151 94.25%

Holding current value

$3.35 Million

Previous $56.2 Million 93.68%

% of portfolio

0.0%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$13.0 - $15.08 $12.2 Million - $14.2 Million	-939,545 Reduced 21.62%	3,406,606 $48.4 Million
Q2 2024 Aug 14, 2024	BUY	$12.6 - $13.67 $25.5 Million - $27.7 Million	2,023,707 Added 87.14%	4,346,151 $56.2 Million
Q1 2024 May 15, 2024	SELL	$13.89 - $15.04 $57.9 Million - $62.7 Million	-4,170,467 Reduced 64.23%	2,322,444 $32.3 Million
Q4 2023 Feb 14, 2024	BUY	$13.36 - $15.43 $45.5 Million - $52.6 Million	3,407,745 Added 110.46%	6,492,911 $92.7 Million
Q2 2023 Aug 14, 2023	SELL	$15.57 - $17.11 $11.8 Million - $12.9 Million	-754,816 Reduced 19.66%	3,085,166 $48.5 Million
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $24.5 Million - $26.4 Million	1,601,601 Added 71.55%	3,839,982 $63.3 Million
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $15.4 Million - $19.4 Million	1,239,382 Added 124.06%	2,238,381 $34.9 Million
Q3 2022 Nov 14, 2022	SELL	$12.8 - $28.65 $3.13 Million - $7 Million	-244,423 Reduced 19.66%	998,999 $13 Million
Q2 2022 Aug 15, 2022	BUY	$13.12 - $15.03 $7.44 Million - $8.53 Million	567,291 Added 83.9%	1,243,422 $17.5 Million
Q1 2022 May 16, 2022	BUY	$13.54 - $15.35 $8.55 Million - $9.69 Million	631,280 Added 1407.5%	676,131 $9.68 Million
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $384,326 - $478,584	29,182 Added 186.24%	44,851 $611,000
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $3.75 Million - $3.97 Million	-230,243 Reduced 93.63%	15,669 $257,000
Q2 2021 Aug 16, 2021	BUY	$16.55 - $18.64 $1.8 Million - $2.02 Million	108,463 Added 78.91%	245,912 $4.14 Million
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $2.3 Million - $2.74 Million	137,449 New	137,449 $2.51 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $7.93 Million - $9.78 Million	-515,404 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $6.13 Million - $6.88 Million	-358,519 Reduced 41.02%	515,404 $9.2 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $529,441 - $707,616	-36,288 Reduced 3.99%	873,923 $15.7 Million
Q1 2020 May 14, 2020	BUY	$13.02 - $20.31 $7.46 Million - $11.6 Million	572,940 Added 169.88%	910,211 $13.8 Million
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $5.69 Million - $7.03 Million	337,271 New	337,271 $6.65 Million
Q3 2019 Nov 14, 2019	SELL	$16.15 - $17.99 $3.03 Million - $3.37 Million	-187,487 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$16.58 - $20.49 $2.91 Million - $3.59 Million	175,256 Added 1432.88%	187,487 $3.32 Million
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $31.9 Million - $39.5 Million	-1,926,978 Reduced 99.37%	12,231 $1.28 Million
Q1 2019 May 14, 2019	BUY	$16.7 - $21.52 $32.2 Million - $41.5 Million	1,926,409 Added 15050.07%	1,939,209 $39.5 Million
Q4 2018 Feb 14, 2019	BUY	$15.64 - $21.1 $200,192 - $270,080	12,800 New	12,800 $215,000

Others Institutions Holding TAK

# of Institutions

336

Shares Held

73.8M

Call Options Held

1.96M

Put Options Held

165K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.6B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account